Profound Medical (PROF) Cash from Financing Activities (2024 - 2025)
Profound Medical (PROF) posted quarterly Cash from Financing Activities of $41.4 million for Q4 2025, up 16.91% year-over-year from $35.4 million in Q4 2024, and up 14385.52% quarter-over-quarter from -$290000.0 in Q1 2025.
Profound Medical (PROF) Cash from Financing Activities (2024 - 2025) Analysis & Trends
Profound Medical's Cash from Financing Activities history runs 2 years deep, the most recent figure standing at $41.4 million for Q4 2025.
- In Q4 2025, Cash from Financing Activities rose 16.91% year-over-year to $41.4 million; the TTM figure through Dec 2025 stood at $41.1 million (down 24.79% YoY), while the FY2025 annual figure was $41.1 million, down 24.79% from the prior year.
- Cash from Financing Activities for Q4 2025 stood at $41.4 million, up from -$290000.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $41.4 million in Q4 2025, with the low at -$603000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Profound Medical | 247.18 Mn | 208.91 Mn | 1.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 41.43 Mn |
| Dec 31, 2025 | 41.43 Mn |
| Mar 31, 2025 | -290,000.00 |
| Mar 31, 2025 | -290,000.00 |
| Dec 31, 2024 | 35.44 Mn |
| Dec 31, 2024 | 35.44 Mn |
| Sep 30, 2024 | -592,000.00 |
| Sep 30, 2024 | -592,000.00 |
| Jun 30, 2024 | -603,000.00 |
| Jun 30, 2024 | -603,000.00 |
| Mar 31, 2024 | 20.46 Mn |
| Mar 31, 2024 | 20.46 Mn |